Trump administration unveils plans to end gender-affirming care for minors
Proposal would prohibit Medicaid funds from being used to cover puberty blockers, hormone treatments or surgical procedures
TL;DR
- New actions aim to eliminate transition-related medical care for minors.
- Hospitals offering puberty blockers, hormone treatments, or surgeries to minors could be barred from Medicare/Medicaid.
- Medicaid funds would be prohibited from covering this type of care.
- FDA to send warnings to companies selling breast binders to minors for gender dysphoria.
- Effort to reverse Biden-era policy classifying gender dysphoria as a disability.
- Moves criticized by health experts, lawmakers, and LGBTQ+ rights organizations.
- Past actions include executive orders limiting transgender healthcare access and an HHS review questioning evidence for gender-affirming care in minors.